PEPG Q2 2025 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena

PEPGPepGen Inc.

$435M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$24M

Net Income

-$23M

EPS (Diluted)

$-0.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$102M

Total Liabilities

$31M

Stockholders' Equity

$71M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$24M	-$30M	+21.3%
Net Income	-$23M	-$28M	+18.5%